1.02
-0.01(-0.97%)
Currency In USD
| Previous Close | 1.03 |
| Open | 1.03 |
| Day High | 1.04 |
| Day Low | 1.02 |
| 52-Week High | 3.26 |
| 52-Week Low | 1 |
| Volume | 44,334 |
| Average Volume | 1.52M |
| Market Cap | 10.45M |
| PE | -0.82 |
| EPS | -1.24 |
| Moving Average 50 Days | 1.18 |
| Moving Average 200 Days | 1.49 |
| Change | -0.01 |
If you invested $1000 in Cocrystal Pharma, Inc. (COCP) 10 years ago, it would be worth $3.63 as of November 18, 2025 at a share price of $1.02. Whereas If you bought $1000 worth of Cocrystal Pharma, Inc. (COCP) shares 5 years ago, it would be worth $98.84 as of November 18, 2025 at a share price of $1.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cocrystal Pharma Insiders Purchase $1.03 Million in Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Oct 30, 2025 12:00 PM GMT
Investment by Directors and Management demonstrates confidence in the Company Potential for an additional $1.8 million upon the exercise in full of warrants BOTHELL, Wash., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (th
Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program
GlobeNewswire Inc.
Oct 27, 2025 12:00 PM GMT
BOTHELL, Wash., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces it has received a Small Business Innovation Research (SBIR) Phase I award from the National Institutes of Health (NIH)
Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
GlobeNewswire Inc.
Oct 02, 2025 12:00 PM GMT
BOTHELL, Wash., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the Noble Capital Markets Emerging Growth Virtual